Biostate AI (Series A)

Funding Details
Awarder
Inbox
Date Award
May 20, 2025
Vertical
Artificial Intelligence / Molecular Diagnostics
Funding URL
View Funding Page
Funding Amount:
$12,000,000

Company Info
Traction
Biostate has run RNAseq on over 10,000 samples from over 150 collaborators and customers from leading institutions and secured agreements to process several hundred thousand unlabeled samples annually.
Organizations Involved
Cornell, Accelerated Cure Project
Founders
David Zhang, Ashwin Gopinath
Company Description
Biostate AI is a startup building generative AI that predicts the evolution of human disease and drug response based on RNA sequencing data. Its patented wetlab technologies, including BIRT, allow affordable and scalable collection of massive amounts of transcriptomic and genomic data.
Market
Molecular Research / Precision Medicine
Location
Houston, Texas, USA
Coinvestors
Accel, Gaingels, Mana Ventures, InfoEdge Ventures, Matter Venture Partners, Vision Plus Capital, Catapult Ventures, Dario Amodei, Mike Schnall-Levin, Emily Leproust

Links